An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

with or without resistance to other first-line anti-TB drugs, is classified as MDR-TB. Extensively drug-resistant TB (XDR-TB) includes cases that, in addition to MDR-TB criteria, are also ...

More than half the TB patients in India seek private medical care. The current system of treatment of TB is confined to either public hospitals where treatment is given free but in an ambience which ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

European tuberculosis surveillance report underscores the gravity of the situation in the WHO European region.1 Across 53 ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

New Delhi: Union Science and Technology Minister Jitendra Singh on Monday announced the completion of genome sequencing of 10,000 isolates of Mycobacterium Tuberculosis, which has the potential to ...

When the Global Drug Facility for TB was launched in 2021 to procure high-quality anti-TB drugs and diagnostics for low- and middle-income countries, USAID also played a crucial funding role to ...

the TB bacteria had developed resistance to first line anti-TB drugs, and she had to be put on the painstaking treatment for drug resistant TB. Priya’s story is far from unique, TB remains one ...

"AKG-100 demonstrated promising preclinical data, and we believe that the addition of AKG-100 to drug-resistant TB treatment regimens will improve anti-TB activity and provide a favourable safety ...